切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2024, Vol. 18 ›› Issue (05) : 513 -516. doi: 10.3877/cma.j.issn.1674-3946.2024.05.012

论著

ICG荧光显影Laennec膜入路腹腔镜解剖性肝切除的临床研究
胡森焱1, 徐冬1, 方健1, 谢冬冬1, 王财庆,1   
  1. 1. 211300 南京,江苏省南京市高淳区人民医院普外科
  • 收稿日期:2023-09-18 出版日期:2024-10-26
  • 通信作者: 王财庆

Clinical study of laparoscopic anatomic hepatectomy by laennec membrane approach with ICG fluorescence imaging

Senyan Hu1, Dong Xu1, Jian Fang1, Dongdong Xie1, Caiqing Wang,1   

  1. 1. Department of General Surgery, Gaochun District People's Hospitalof Nanjing , Nanjing Jiangsu Province 211300, China
  • Received:2023-09-18 Published:2024-10-26
  • Corresponding author: Caiqing Wang
  • Supported by:
    Research Project of Jiangsu Provincial Health Commission(Z2020069); 2023 Jiangsu University Medical Education Collaborative Innovation Funding(JDYY2023025)
引用本文:

胡森焱, 徐冬, 方健, 谢冬冬, 王财庆. ICG荧光显影Laennec膜入路腹腔镜解剖性肝切除的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 513-516.

Senyan Hu, Dong Xu, Jian Fang, Dongdong Xie, Caiqing Wang. Clinical study of laparoscopic anatomic hepatectomy by laennec membrane approach with ICG fluorescence imaging[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(05): 513-516.

目的

探究ICG荧光显影技术在laennec膜入路腹腔镜解剖性肝切除术(LALR)中的应用效果。

方法

回顾性分析2019年6月至2022年12月74例肝细胞癌患者资料,所有患者均行Laennec膜入路LALR,根据手术是否应用ICG分为ICG组(n=39)和非ICG组(n=35)。采用SPSS 24.0分析数据。两组患者围手术期指标、肝功能指标等计量资料用()表示,采用独立样本t检验;术后并发症等计数资料用[n%)]表示,采用χ2检验;生存分析采用Kaplan-Meier法并行Log-Rank检验。P<0.05为差异有统计学意义。

结果

ICG组患者手术时间、肝门阻断时间、拔除引流管时间、术后住院时间显著短于非ICG组,切缘距离长于非ICG组,术中出血量少于非ICG组(P<0.05);两组患者术后3d时谷丙转氨酶(ALT)、谷草转氨酶(AST)、血清白蛋白(ALB)水平较术前显著升高,且非ICG组显著高于ICG组(P<0.05);两组患者术后并发症总发生率(10.4% vs. 14.3%)、两组患者累积无病生存率(DFS)、总生存率(OS)比较(74.4% vs. 68.6%,79.5% vs. 71.4%),差异均无统计学意义(P>0.05)。

结论

在laennec膜入路LALR中应用ICG荧光显影技术可精确定位肿瘤位置并在肝实质内实时追踪、确定切肝界面,更利于指导手术精确切除,最大限度保护正常肝实质,缩短术中肝门阻断时间和手术时间,减少术中出血量,促进患者术后肝功能恢复。

Objective

To investigate the efficacy of ICG fluorescence imaging in laparoscopic anatomic hepatectomy by laennec membrane approach.

Methods

74 patients with hepatocellular carcinoma admitted to our hospital from June 2019 to December 2022 were retrospectively selected as study subjects. All patients underwent laennec membrane approach laparoscopic anatomic hepatectomy, and were divided into ICG group (n=39) and non-ICG group (n=35) according to whether ICG was used in surgery. SPSS 24.0 was used to analyze the data. Perioperative indexes, liver function indexes and other measurement data of the two groups were expressed with (), and independent sample t test was used. The statistical data of postoperative complications were expressed by [n (%)] and χ2 test was used. Kaplan-Meier method and Log-Rank test were used for survival analysis. P<0.05 was considered statistically significant.

Results

The operation time, hilar occlusion time, drainage tube removal time and postoperative hospitalization time in ICG group were significantly shorter than those in non-ICG group, the incision margin distance was longer than that in non-ICG group, and the intraoperative blood loss was less than that in non-ICG group (P<0.05). The levels of ALT, AST and ALB in both groups were significantly higher than those before surgery, and the non-ICG group was significantly higher than the ICG group (P<0.05).There was no significant difference in the total incidence of postoperative complications between the two groups (10.4% vs 14.3%). Cumulative DFS and OS were compared between the two groups (74.4% vs. 68.6%, 79.5% vs. 71.4%), and there was no statistical significance (P>0.05).

Conclusion

The application of ICG fluorescence imaging technology in laennec membrane approach laparoscopic anatomic hepatectomy can accurately locate the tumor location and track and determine the hepatectomy interface in real time within the hepatic parenchyma, which is more conducive to guiding the accurate surgical resection, protecting the normal hepatic parenchyma to the maximum extent, shortening the intraoperative portal blocking time and operation time, reducing intraoperative blood loss, and promoting the postoperative liver function recovery of patients.

表1 两组患者围手术期指标比较
表2 两组患者围手术期指标比较(
表3 两组患者肝功能指标比较(
表4 两组患者并发症发生情况比较(例)
图1 两组患者术后累积DFSOS比较
[1]
曹毛毛,李贺,孙殿钦,等.全球肝癌2020年流行病学现状[J].中华肿瘤防治杂志,2022,29(05):322-328.
[2]
Monden KOhno KHayashi S,et al. Hepatic vein anatomy related to Laennec's capsule for liver resection[J]. J Hepatobiliary Pancreat Sci2023,30(5):551-557.
[3]
Zhang YPShi NJian ZX,et al. Research progression and application of Laennec capsule in liver[J]. Zhonghua Wai Ke Za Zhi2020,58(8):646-648.
[4]
Kamiyama TKakisaka TOrimo T. Current role of intraoperative ultrasonography in hepatectomy[J]. Surg Today2021,51(12):1887-1896.
[5]
Gavriilidis PEdwin BPelanis E,et al. Navigated liver surgery: State of the art and future perspectives[J]. Hepatobiliary Pancreat Dis Int2022,21(3):226-233.
[6]
方驰华,王晓颍,刘允怡.计算机辅助联合吲哚菁绿分子荧光影像技术在肝脏肿瘤诊断和手术导航中应用指南(2019版)[J].中国实用外科杂志,2019,39(07):641-650+654.
[7]
冯涛,詹兴云,林斯锋.三种不同入路在腹腔镜解剖性肝切除术中的应用价值回顾性分析[J/CD].中华普外科手术学杂志(电子版),2022,16(01):72-75.
[8]
Zhang YShi NZou Y,et al. The characteristics of Laennec's capsule around the hepatic veins: A histological study based on 71 liver surgical specimens[J]. Ann Gastroenterol Surg2022,7(2):287-294.
[9]
余德才,曹亚娟,张来柱.腹腔镜解剖性右半肝切除治疗进展期肝细胞肝癌(Laennec入路联合背侧入路)[J].中华腔镜外科杂志(电子版),2021,14(04):235-236.
[10]
Hu WZhang GChen M,et al. Laennec's approach for laparoscopic anatomical hemihepatectomy[J]. World J Surg Oncol2021,19(1):295.
[11]
Wakabayashi TCacciaguerra ABAbe Y,et al. Indocyanine Green Fluorescence Navigation in Liver Surgery: A Systematic Review on Dose and Timing of Administration[J]. Ann Surg2022,275(6):1025-1034.
[12]
李依川,彭彬,辛大平,等.三种肝血流阻断术的左半肝切除术治疗原发性肝癌的对比研究[J/CD].中华普外科手术学杂志(电子版),2021,15(05):566-569.
[13]
Dong XFZhong JTChen YY,et al. Research progress in the Hepatobiliary Surgery operation of hepatic hilar plate system[J]. Zhonghua Wai Ke Za Zhi2020,58(7):555-557.
[14]
Liu DFang JMChen XQ. Clinical significance of half-hepatic blood flow occlusion technology in patients with hepatocellular carcinoma with cirrhosis[J]. World J Clin Cases2022,10(24):8547-8555.
[15]
Tsuge MKawaoka TOka S. Factors for the recurrence of hepatocellular carcinoma after hepatic resection[J]. J Gastroenterol2023,58(3):292-293.
[1] 燕速, 霍博文. 腹腔镜食管胃结合部腺癌根治性切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 13-13.
[2] 母德安, 李凯, 张志远, 张伟. 超微创器械辅助单孔腹腔镜下脾部分切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 14-14.
[3] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[4] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[5] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[6] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[7] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[8] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[9] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[10] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[11] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[12] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
[13] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-143.
[14] 李凯, 陈淋, 苏怀东, 向涵, 张伟. 超微创器械在改良单孔腹腔镜巨大肝囊肿开窗引流及胆囊切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 144-144.
[15] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-145.
阅读次数
全文
5
HTML PDF
最新录用 在线预览 正式出版 最新录用 在线预览 正式出版
0 0 0 0 0 5

  来源 本网站 其他网站
  次数 4 1
  比例 80% 20%

摘要
43
最新录用 在线预览 正式出版
0 0 43
  来源 本网站 其他网站
  次数 8 36
  比例 18% 82%